Emerson Electric Statistics
Total Valuation
EMR has a market cap or net worth of $62.76 billion. The enterprise value is $71.54 billion.
| Market Cap | 62.76B |
| Enterprise Value | 71.54B |
Important Dates
The next confirmed earnings date is Wednesday, May 8, 2024, before market open.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | Feb 15, 2024 |
Share Statistics
EMR has 571.70 million shares outstanding. The number of shares has decreased by -2.28% in one year.
| Shares Outstanding | 571.70M |
| Shares Change (YoY) | -2.28% |
| Shares Change (QoQ) | -0.28% |
| Owned by Insiders (%) | 0.35% |
| Owned by Institutions (%) | 77.31% |
| Float | 569.00M |
Valuation Ratios
The trailing PE ratio is 5.71 and the forward PE ratio is 19.79. EMR's PEG ratio is 2.30.
| PE Ratio | 5.71 |
| Forward PE | 19.79 |
| PS Ratio | 3.94 |
| Forward PS | 3.49 |
| PB Ratio | 3.04 |
| P/FCF Ratio | 248.05 |
| PEG Ratio | 2.30 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.60, with an EV/FCF ratio of 282.76.
| EV / Earnings | 6.49 |
| EV / Sales | 4.50 |
| EV / EBITDA | 5.60 |
| EV / EBIT | 6.18 |
| EV / FCF | 282.76 |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.12 |
| Quick Ratio | 0.62 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 0.85 |
| Debt / FCF | 42.92 |
| Interest Coverage | 385.60 |
Financial Efficiency
Return on equity (ROE) is 60.30% and return on invested capital (ROIC) is 6.79%.
| Return on Equity (ROE) | 60.30% |
| Return on Assets (ROA) | 26.00% |
| Return on Capital (ROIC) | 6.79% |
| Revenue Per Employee | $237,448 |
| Profits Per Employee | $164,627 |
| Employee Count | 67,000 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 3.69 |
Taxes
In the past 12 months, EMR has paid $508.00 million in taxes.
| Income Tax | 508.00M |
| Effective Tax Rate | 4.40% |
Stock Price Statistics
The stock price has increased by +28.25% in the last 52 weeks. The beta is 1.37, so EMR's price volatility has been higher than the market average.
| Beta (1Y) | 1.37 |
| 52-Week Price Change | +28.25% |
| 50-Day Moving Average | 109.95 |
| 200-Day Moving Average | 97.92 |
| Relative Strength Index (RSI) | 43.35 |
| Average Volume (30 Days) | 2,716,901 |
Short Selling Information
The latest short interest is 6.03 million, so 1.05% of the outstanding shares have been sold short.
| Short Interest | 6.03M |
| Short Previous Month | 6.60M |
| Short % of Shares Out | 1.05% |
| Short % of Float | 1.06% |
| Short Ratio (days to cover) | 2.28 |
Income Statement
In the last 12 months, EMR had revenue of $15.91 billion and earned $11.03 billion in profits. Earnings per share was $19.23.
| Revenue | 15.91B |
| Gross Profit | 7.72B |
| Operating Income | 2.24B |
| Pretax Income | 11.54B |
| Net Income | 11.03B |
| EBITDA | 12.78B |
| EBIT | 11.57B |
| Earnings Per Share (EPS) | $19.23 |
Balance Sheet
The company has $2.08 billion in cash and $10.86 billion in debt, giving a net cash position of -$8.78 billion or -$15.36 per share.
| Cash & Cash Equivalents | 2.08B |
| Total Debt | 10.86B |
| Net Cash | -8.78B |
| Net Cash Per Share | -$15.36 |
| Equity / Book Value | 20.67B |
| Book Value Per Share | 36.16 |
| Working Capital | 901.00M |
Cash Flow
In the last 12 months, operating cash flow was $634.00 million and capital expenditures -$381.00 million, giving a free cash flow of $253.00 million.
| Operating Cash Flow | 634.00M |
| Capital Expenditures | -381.00M |
| Free Cash Flow | 253.00M |
| FCF Per Share | $0.44 |
Margins
Gross margin is 48.54%, with operating and profit margins of 14.08% and 69.33%.
| Gross Margin | 48.54% |
| Operating Margin | 14.08% |
| Pretax Margin | 72.52% |
| Profit Margin | 69.33% |
| EBITDA Margin | 80.34% |
| EBIT Margin | 72.71% |
| FCF Margin | 1.59% |
Dividends & Yields
This stock pays an annual dividend of $2.10, which amounts to a dividend yield of 1.91%.
| Dividend Per Share | $2.10 |
| Dividend Yield | 1.91% |
| Dividend Growth (YoY) | 0.97% |
| Years of Dividend Growth | 67 |
| Payout Ratio | 10.92% |
| Buyback Yield | 2.28% |
| Shareholder Yield | 4.20% |
| Earnings Yield | 17.58% |
| FCF Yield | 0.40% |
Analyst Forecast
The average price target for EMR is $116.25, which is 5.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $116.25 |
| Price Target Difference | 5.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (5Y) | 7.70% |
| EPS Growth Forecast (5Y) | -20.22% |
Stock Splits
The last stock split was on December 12, 2006. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 12, 2006 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
EMR has an Altman Z-Score of 4.27 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.27 |
| Piotroski F-Score | 7 |